Forbion Growth Opportunities Fund Iii Cooperatief U.A. bought $64.8M of Braveheart Bio, Inc. (BRVE) stock

Forbion Growth Opportunities Fund Iii Cooperatief U.A., 10% owner of Braveheart Bio, Inc. (BRVE), bought 3,600,000 shares of BRVE stock worth $64.8M, per an SEC Form 4 filed Aug 7, 2026.

It was an open-market purchase.

The trade was reported on Aug 7, 2026.

BRVE has moved -16.6% since the trade date, from $30.00 to $25.02 (Sep 21, 2026 close).